Quintrio
Home

REAL ESTATE INVESTMENT TRUSTS

Ventas, Inc.

VTR

Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.

Last trade $87.91
Day change -$0.975 (-1.10%)
Day range $87.26 – $88.91
Volume 610,607
Market cap $47.00B

Open XNYS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

Valuation

Market capitalization
$47B
Price / earnings
179.35×
Price / book
2.97×
Price / sales
6.94×
EV / sales
8.75×
EV / EBITDA
24.06×

Profitability

Earnings per share
$0.50
Return on assets
0.86%
Return on equity
1.66%
Dividend yield
2.08%

Liquidity and leverage

Debt / equity
0.79×
Current ratio
0.02×
Quick ratio
0.02×
Cash ratio
0.01×

Cash flow

Price / cash flow
24.58×
Price / free cash flow
—
Free cash flow
-$415.53M

Ratios use trailing-twelve-month financials and market data as of Nov 16, 2026.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

Income statement for VTR, quarterly periods
Line itemQ3 FY2026 Sep 30, 2026Q2 FY2026 Jun 30, 2026Q1 FY2026 Mar 31, 2026Q4 FY2025 Dec 31, 2025Q3 FY2025 Sep 30, 2025Q2 FY2025 Jun 30, 2025Q1 FY2025 Mar 31, 2025Q4 FY2024 Dec 31, 2024
Revenue$1.82B$1.73B$1.65B$1.57B$1.48B$1.42B$1.35B$1.28B
Cost of revenue$1.1B$1.04B$1B$935.79M$868.4M$825.27M$783.88M$739.51M
Gross profit$713.1M$686.91M$652.91M$636.6M$610.89M$589.75M$571.11M$543.85M
Selling, general and administrative$47.7M$46.99M$62.75M$36.04M$40.39M$42.86M$53.15M$36.48M
Research and development$0$0$0$0$0$0$0$0
Total operating expenses$513.21M$474.42M$463.86M$389.35M$418.04M$402.67M$383.89M$374.47M
Operating income$199.89M$212.5M$189.06M$247.25M$192.85M$187.09M$187.22M$169.38M
Interest expense-$161.39M-$160.03M-$156.14M-$154.47M-$158.12M-$150.3M-$149.36M-$153.21M
Income before taxes$53.44M$54.42M$50.46M$119.33M$45.72M$76.47M$41.11M$58.06M
Income taxes-$19.3M-$25.62M-$15.94M-$1.12M-$6.35M$3.87M-$10.56M-$45.54M
Net income$67.28M$72.22M$59.05M$72.99M$68.71M$71.46M$48.36M$58.73M
Net income attributable to common shareholders$65.38M$70.57M$55.91M$70.2M$66.05M$68.26M$46.87M$56.84M
EBITDA$656.05M$636.92M$583.4M$585.49M$552.39M$536.33M$512.53M$456.76M
Basic earnings per share$0.13$0.14$0.12$0.15$0.14$0.15$0.11$0.13
Diluted earnings per share$0.13$0.14$0.11$0.15$0.14$0.15$0.10$0.13

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
Zacks Investment Research

Ventas Q3 FFO & Revenues Beat Estimates on Strong SHOP Growth

Ventas (VTR) beat Q3 earnings expectations with normalized FFO of 99 cents per share (up 10% YoY) and revenues of $1.83 billion (up 23% YoY). Senior housing same-store cash NOI grew 15.5% with occupancy improving 290 bps to 92.1%. The company raised 2026 FFO guidance to $3.87-$3.90 per share, driven by $5.2 billion in year-to-date senior housing investments. Leverage improved with net debt-to-EBITDA at 4.4x.

Zacks Investment Research

Ventas (VTR) Reports Q3 Earnings: What Key Metrics Have to Say

Ventas (VTR) reported Q3 2026 revenue of $1.83 billion, up 23% year-over-year, beating consensus estimates by 3.99%. EPS came in at $0.99 versus $0.14 in the prior year quarter, representing a 1.02% EPS surprise. The company showed strong performance in resident fees and services (+33.3% YoY) and income from loans and investments (+120.2% YoY), though interest income declined 53.1%. The stock carries a Zacks Rank #3 (Hold) rating.

Zacks Investment Research

Ventas (VTR) Q3 FFO and Revenues Top Estimates

Ventas (VTR) reported quarterly FFO of $0.99 per share, beating consensus estimates of $0.98, with revenues of $1.83 billion exceeding expectations by 3.99%. The company has outperformed the S&P 500 by about 1% year-to-date. However, mixed estimate revision trends resulted in a Zacks Rank #3 (Hold) rating, suggesting near-term performance in line with the market. Chatham Lodging (CLDT) is expected to report results on November 5 with projected earnings of $0.42 per share, representing 31.3% year-over-year growth.

Zacks Investment Research

Equinix to Post Q3 Earnings: What's in Store for the Stock?

Equinix (EQIX) is set to report Q3 2026 earnings on October 28, with consensus estimates projecting 11% revenue growth to $2.57 billion and 6.9% AFFO per share growth to $10.51. Strong demand for interconnected data center infrastructure driven by AI adoption and cloud expansion is expected to support growth, though high interest expenses may be a headwind. The company's quantitative model does not predict a surprise beat this quarter.

Zacks Investment Research

BXP to Post Q3 Earnings: Is the Stock a Portfolio Must-Have?

BXP, Inc. is scheduled to report Q3 2026 results on October 27, with revenues projected to rise 3.7% and FFO per share expected to grow 3.5% year-over-year. The office REIT is positioned to benefit from strong demand for premier office spaces and positive U.S. office market recovery, though competitive leasing conditions and higher operating costs may limit margin expansion.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

Ex-dividendAmount / sharePay dateType
Sep 30, 2026$0.52Oct 15, 2026recurring
Jun 30, 2026$0.52Jul 16, 2026recurring
Mar 31, 2026$0.52Apr 16, 2026recurring
Dec 31, 2025$0.48Jan 15, 2026recurring
Sep 30, 2025$0.48Oct 16, 2025recurring

Stock splits

Historical share-structure events and their execution dates.

Updated daily

No stock split records found.